Survival Time for Advanced Leukemia Patients
There is no definitive time frame for how long advanced leukemia patients can live. With aggressive treatment, they may survive for 1-3 years or even longer; without any treatment, the survival period is typically around six months.
Aggressive Treatment Options
1.
Chemotherapy: For patients with low-to-intermediate-risk acute myeloid leukemia, allogeneic hematopoietic stem cell transplantation can be considered after induction remission. For high-risk patients, a comprehensive treatment plan focusing on systemic chemotherapy is necessary, with commonly used drugs including daunorubicin injection and cytarabine injection. Standardized chemotherapy can help control the disease and extend patients' lifespan, typically ranging from 2 to 5 years.
2.
Targeted Therapy: For patients with chronic myeloid leukemia, medications such as imatinib mesylate tablets and nilotinib capsules can be prescribed under medical supervision to alleviate symptoms, inhibit tumor growth and spread, and potentially prolong survival, often enabling patients to live for over 3 years.
Without Any Treatment
As leukemia is a malignant disease, failure to take prompt and effective measures may lead to organ failure and death, resulting in a shorter survival period of approximately half a year to one year. It is recommended that patients maintain a positive mindset and actively cooperate with their doctors for targeted treatments, which can help improve quality of life and extend survival time.
